CDC international HIV prevention research activities among injection drug users in Thailand and Russia

Journal of Urban Health

Volumn 82, Issue SUPPL. 4, 2005, Pages

  Greenberg, Alan E ^a,e   Tappero, Jordan ^b   Choopanya, Kachit ^c   Van Griensven, Frits ^a   Martin, Mike ^c   Vanichseni, Suphak ^c   Santibanez, Scott ^a   Molotilov, Valerie ^d   Hader, Shannon ^b   Broyles, Laura N ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Bangkok Metropolitan Administration   (Thailand)

^d AIDS and Infect Dis Prev Center   (Russian Federation)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

HIV; IDUs; Research; Russia; Thailand

Indexed keywords

GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; ILLICIT DRUG; TENOFOVIR;

ADULT; CLINICAL RESEARCH; CLINICAL TRIAL; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HEALTH PROMOTION; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; INTRAVENOUS DRUG ABUSE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MULTICENTER STUDY; PATIENT EDUCATION; PATIENT INFORMATION; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; SEROCONVERSION; SEXUALITY;

AIDS VACCINES; BEHAVIORAL RESEARCH; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; MALE; RISK-TAKING; RUSSIA; SEXUAL PARTNERS; SUBSTANCE ABUSE, INTRAVENOUS; THAILAND; UNITED STATES;

EID: 26644437222     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1093/jurban/jti105     Document Type: Conference Paper

References (27)

1. Shaffer N, Chuachoowong R, Mock P, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomized controlled trial. Lancet. 1999;353:773-780.
2. Wiktor SZ, Ekpini ER, Karon JM, et al. Short-course of oral zidovudine to prevent mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomized trial. Lancet. 1999;353:781-785.
3. Kilmarx PH, Supawitkul S, Yanpaisarn S, et al. A year-long, randomized controlled trial of a carageenan gel as a vaginal microbicide: effect on reproductive tract infection rates. In: 14th International Conference on AIDS; July 7-12, 2002; Barcelona, Spain.
4. Van Damme L, Ramjee G, Alary M, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 2002;360:971-977.
5. Choopanya K, Tappero J, Pitisuttithum P, et al. Final results of a phase III HIV vaccine efficacy trial among injection drug users in Thailand. In: XV International AIDS Conference; July 11-16, 2004; Bangkok, Thailand. Abstract ThOrA1427.
6. Wiktor SZ, Sassan-Morokro M, Grant AD, et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomized controlled trial. Lancet. 1999;353:1469-1475.
7. Weidle PJ, Malamba S, Mwebaze R, et al. Assessment of a pilot antiretroviral drug therapy program in Uganda: patients' response, survival and drug resistance. Lancet. 2002;360:34-40.
8. Centers for Disease Control Global AIDS Program Website. Global AIDS program. Available at: http://www.cdc.gov/nchstp/od/gap/. Accessed June 14, 2005.
9. President's Emergency Plan for AIDS Relief Website. President's emergency plan for AIDS relief. Available at: http://www.usaid.gov/our_work/ global_health/aids/pepfar.html. Accessed June 14, 2005.
10. Mastro TD, Kitayaporn D, Weninger BG, et al. Estimating the number of HIV-infected injection drug users in Bangkok: a capture-recapture method. Am J Public Health. 1994;84:1094-1099.
11. Vanichseni S, Kitayaporn D, Mastro TD, et al. Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand. AIDS. 2001;15:397-405.
12. Martin M, Mansakul W, Tappero JW, et al. Care and treatment of HIV-infected persons during an HIV vaccine efficacy trial, Bangkok, Thailand. In: International AIDS Vaccine Conference; September 18-21, 2003; New York, NY.
13. Vanichseni S, Tappero JW, Pitisuttithum P, et al. Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX B/E HIV vaccine trial, Bangkok, Thailand. AIDS. 2004;18:311-316.
14. Kazionny B, Wells C, Kluge H, Gusseynova N, Molotilov V. Implications of the growing HIV epidemic for TB control in Russia. Lancet. 2001;358:1513-1514.
15. Tappero JW, Siraprapasiri T, Levine WC, et al. The Thailand MoPH - U.S. CDC collaboration in Asia. In: Lu, Y, Essex, M, eds. AIDS in Asia. Norwell, MA: Kluwer Academic/Plenum Publishers; 2004.
16. MacQueen KM, Vanichseni S, Kitayaporn D, et al. Willingness of injecting drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand. J Acquir Immune Defic Syndr. 1999;21:243-251.
17. Pitisuttithum P, Berman PW, Phonrat B, et al. Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1. J Acquir Immune Defic Syndr. 2004;37:1160-1165.
18. Ramos A, Hu DJ, Nguyen L, et al. Intersubtype human immunodeficiency virus type I superinfection following seroconversion to primary infection in two injection drug users. J Virol. 2002;76:7444-7452.
19. Hu DJ, Vanicheseni S, Mastro TD, et al. Viral load differences in early infection with two HIV-1 subtypes. AIDS. 2001;15:683-691.
20. Ramos A, Nguyen L, Hu DJ, et al. New HIV-1 CRF01_AE/B recombinants displaying unique distribution of breakpoints from incident infections among injection drug users in Thailand. AIDS Res Hum Retroviruses. 2003;19:667-674.
21. van Griensven F, Keawkungwal J, Tappero JW, et al. Lack of increased HIV risk behavior among injecting drug users participating in the AIDSVAX B/E HIV vaccine trial in Bangkok, Thailand. AIDS. 2004;18:295-301.
22. Molotilov V, Sofronova R, Gusseynova N, et al. Rapid increase in HIV rates - Orel Oblast, Russia Federation, 1999-2001. MMWR Morb Mortal Wkly Rep. 2003;52:657-660.
23. Santibanez SS, Sofronova R, Nelson RJ, et al. Building on Russian HIV surveillance: the CDC Orel AIDS center enhanced surveillance project, 2002-2003. In: XV International AIDS Conference; July 11-16, 2004; Bangkok, Thailand.
24. Bobkov AF, Kazennova EV, Selimova LM, et al. Temporal trends in the HIV-1 epidemic in Russia: predominance of subtype A. J Med Virol. 2004;74:191-196.
25. Hader SL. Rapid rise in HIV rates among injection drug users (IDUs) in rural Russia: Orel Oblast, October 2001. In: Turning Research into Prevention Seminar Series (CDC); April 17, 2002; Atlanta, GA.
26. Broyles L. HIV sexual risk behaviors among female sex partners of injection drug users - Orel, Russia, 2002. In: Centers for Disease Control and Prevention, 52nd Annual Epidemic Intelligence Service (EIS) Conference, April 2, 2003; Atlanta, GA.
27. Pokrovskii VV. HIV infection in Russia: a prediction [in Russian]. Voprosy Virusologii. 2004;49:31-34.